Business Description
Sinclair Pharma PLC
NAICS : 325412
ISIN : GB0033856740
Description
Sinclair Pharma PLC is a United Kingdom-based specialty pharmaceutical company focused on Dermatology, in particular, Aesthetics, Wound care, and Skin care. The group has a direct sales and marketing presence in the top five European markets and a rapidly growing International division concentrated on key emerging markets through long-term multi-product, multi-country, sales & marketing and distribution deals with key strategic partners. The Company's reportable operating segments are International Operations, France, Italy, Germany, UK, and Spain.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.19 | |||||
| Equity-to-Asset | 0.53 | |||||
| Debt-to-Equity | 0.21 | |||||
| Debt-to-EBITDA | -23.71 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 0.81 | |||||
| Beneish M-Score | -1.99 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -11.5 | |||||
| 3-Year EPS without NRI Growth Rate | 70 | |||||
| 3-Year FCF Growth Rate | -16.7 | |||||
| 3-Year Book Growth Rate | -8.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.48 | |||||
| Quick Ratio | 1.15 | |||||
| Days Inventory | 129.72 | |||||
| Days Sales Outstanding | 95.25 | |||||
| Days Payable | 182.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 71.32 | |||||
| Operating Margin % | -17.37 | |||||
| Net Margin % | -9.77 | |||||
| FCF Margin % | -24.67 | |||||
| ROE % | -4.85 | |||||
| ROA % | -2.71 | |||||
| ROIC % | -5.17 | |||||
| ROC (Joel Greenblatt) % | -164.46 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.56 | |||||
| PB Ratio | 1.86 | |||||
| EV-to-EBIT | -28.78 | |||||
| EV-to-EBITDA | -234.4 | |||||
| EV-to-Revenue | 3.86 | |||||
| Price-to-Projected-FCF | 9 | |||||
| Price-to-Median-PS-Value | 1.69 | |||||
| Earnings Yield (Greenblatt) % | -3.48 | |||||
| FCF Yield % | -6.96 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sinclair Pharma PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 52.795 | ||
| EPS (TTM) (€) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0 | ||
| 20-Day SMA (€) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 0.27 - 0.34 | ||
| Shares Outstanding (Mil) | 434.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sinclair Pharma PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sinclair Pharma PLC Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sinclair Pharma PLC Frequently Asked Questions
What is Sinclair Pharma PLC(XPAR:SPH)'s stock price today?
The current price of XPAR:SPH is €0.27. The 52 week high of XPAR:SPH is €0.34 and 52 week low is €0.27.
When is next earnings date of Sinclair Pharma PLC(XPAR:SPH)?
The next earnings date of Sinclair Pharma PLC(XPAR:SPH) is .
Does Sinclair Pharma PLC(XPAR:SPH) pay dividends? If so, how much?
Sinclair Pharma PLC(XPAR:SPH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers